Bad Krozingen, Germany

Arno Martin Friedlein

This inventor holds 2 USPTO granted patents. Top assignees: Dsm IP Assets B.v., Dsm Nutritional Products Inc.. Active years: 2004-2005.


% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2004-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arno Martin Friedlein: Innovator in Nucleic Acid Sequences

Introduction

Arno Martin Friedlein is a notable inventor based in Bad Krozingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequences and their applications.

Latest Patents

Friedlein holds 2 patents that focus on innovative methods related to β,β-carotene 15,15'-monooxygenases. His latest patents include nucleic acid sequences coding for proteins with β,β-carotene 15,15'-monooxygenase activity. These inventions have important applications in diagnostics, vitamin A synthesis, and methods for introducing β,β-carotene 15,15'-monooxygenase cDNA into host cells. Additionally, he has developed patents related to β,β-carotene 15,15'-dioxygenases, which also involve nucleic acid sequences and their uses in similar applications.

Career Highlights

Throughout his career, Friedlein has worked with prominent companies such as DSM IP Assets B.V. and DSM Nutritional Products Inc. His work has significantly advanced the understanding and application of carotenoid enzymes in various fields.

Collaborations

Friedlein has collaborated with notable professionals in his field, including Heinrich Bachmann and Roland Brugger. These collaborations have contributed to the success and impact of his inventions.

Conclusion

Arno Martin Friedlein's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence advancements in diagnostics and vitamin synthesis.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…